Detalhe da pesquisa
1.
GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation.
Immunity
; 50(4): 796-811, 2019 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-30995500
2.
Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis.
Immunity
; 43(1): 187-99, 2015 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-26200014
3.
Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline.
Thorax
; 78(11): 1138-1141, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37657926
4.
Targeting the interleukin-5 pathway improves cough hypersensitivity in patients with severe uncontrolled asthma.
Ann Allergy Asthma Immunol
; 131(2): 203-208.e1, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37100279
5.
A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma.
Br J Clin Pharmacol
; 88(2): 702-712, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34292606
6.
BHLHE40 Promotes TH2 Cell-Mediated Antihelminth Immunity and Reveals Cooperative CSF2RB Family Cytokines.
J Immunol
; 204(4): 923-932, 2020 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31900338
7.
PI3Kδ inhibition prevents IL33, ILC2s and inflammatory eosinophils in persistent airway inflammation.
BMC Immunol
; 22(1): 78, 2021 12 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34920698
8.
Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis.
Br J Haematol
; 195(5): 669-680, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34105142
9.
Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma.
Lancet
; 395(10221): 371-383, 2020 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32007172
10.
Treating severe asthma: Targeting the IL-5 pathway.
Clin Exp Allergy
; 51(8): 992-1005, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33887082
11.
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.
Ann Allergy Asthma Immunol
; 126(6): 696-701.e1, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33548468
12.
Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy.
Int J Mol Sci
; 22(8)2021 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33921360
13.
Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe Asthma.
Int J Mol Sci
; 22(7)2021 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33808110
14.
Cellular Source of Cysteinyl Leukotrienes Following Chlorine Exposure.
Am J Respir Cell Mol Biol
; 63(5): 681-689, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32697598
15.
Biologic Therapies for Severe Asthma.
N Engl J Med
; 386(2): 157-171, 2022 01 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35020986
16.
Severe asthma: When to resort to biological agents.
Pediatr Allergy Immunol
; 31 Suppl 24: 37-39, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32017206
17.
Anti-interleukin (IL)-5 as a steroid-sparing agent in chronic eosinophilic pneumonia.
J Asthma
; 57(1): 82-86, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30444149
18.
Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic.
Respirology
; 25(12): 1243-1249, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32365431
19.
Anti-IL-5 therapies for chronic obstructive pulmonary disease.
Cochrane Database Syst Rev
; 12: CD013432, 2020 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33295032
20.
Exacerbations of Severe Asthma While on Anti-IL-5 Biologics.
J Investig Allergol Clin Immunol
; 30(5): 307-316, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32573459